Please try another search
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.
Name | Age | Since | Title |
---|---|---|---|
Martin Kolb | - | - | Member of Advisory Board |
Parag Phoolchand Saxena | 68 | 2020 | Independent Chairman of the Board |
Laxminarayan Bhat | 59 | 2006 | Founder, CEO, President & Director |
Les D. Funtleyder | 53 | 2020 | Independent Director |
John M. Kane | - | - | Member of Advisory Board |
Richard A. Margolin | 73 | 2020 | Independent Director |
Purav Patel | 42 | 2017 | Independent Director |
Daphne Karydas | 51 | - | Member of Advisory Board |
Roham Zamanian | - | - | Member of Advisory Board |
Leslie Citrome | - | - | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review